TRH ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 80 | 甲状腺ホルモン不応症 | 1 |
80. 甲状腺ホルモン不応症
臨床試験数 : 1 / 薬物数 : 6 - (DrugBank : 3) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 3
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04868045 (ClinicalTrials.gov) | April 27, 2021 | 28/4/2021 | Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer | Evaluation of The Development of Central Resistance to Thyroid Hormone After Prolonged Exposure to Excess Thyroid Hormone in Thyroid Cancer Patients | Thyroid Cancer | Drug: Thyrotropin Releasing Hormone (TRH);Drug: levothyroxine;Other: Hypothyroidism QOL questionnaire | Memorial Sloan Kettering Cancer Center | NULL | Recruiting | 18 Years | N/A | All | 16 | Phase 1 | United States |